This study aims to utilize cardiac magnetic resonance (CMR) to assist in the clinical diagnosis, conduct consecutive assessments for myocardial tissue in pediatrics with myocarditis, and explore effective predictive factors for adverse outcomes in pediatric myocarditis.
Participants will undergo baseline collection, laboratory tests, echocardiography, and CMR. All the consecutive data will be used to analyze the association with the diagnosis and prognosis of pediatric myocarditis.
Eligibility
Sex
ALL
Min age
1 Year
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Patients diagnosed or suspected pediatric myocarditis based on Diagnostic Recommendation for Myocarditis in Children (version 2018).
* Age between 1 to 18 years old.
Exclusion Criteria:
* Previous history of cardiovascular disease ( e.g. congenital heart disease, cardiomyopathy, rheumatic heart disease, valvular disease ).
* MRI examination contraindications ;
* Gadolinium contrast agent contraindications ;
* CT examination contraindications ;
* Comparison of iodine content.
Primary outcome measure(s)
Adverse cardiovascular events — 10 years after the onset including all-cause death, orthotopic heart transplantation(HTx), malignant arrhythmia, readmission due to heart failure, progression to DCM.
Trial sites (1)
Facility
City
Region
Status
West China Second University Hospital, Sichuan University
Chengdu
Sichuan
More West China Second University Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.